Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.

Antimicrobial Agents and Chemotherapy
Jose L del PozoRobin Patel

Abstract

Bacterial biofilms are resistant to conventional antimicrobial agents. Prior in vitro studies have shown that electrical current (EC) enhances the activities of aminoglycosides, quinolones, and oxytetracycline against Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus epidermidis, Escherichia coli, and Streptococcus gordonii. This phenomenon, known as the bioelectric effect, has been only partially defined. The purpose of this work was to study the in vitro bioelectric effect on the activities of 11 antimicrobial agents representing a variety of different classes against P. aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and S. epidermidis. An eight-channel current generator/controller and eight chambers delivering a continuous flow of fresh medium with or without antimicrobial agents and/or EC to biofilm-coated coupons were used. No significant decreases in the numbers of log(10) CFU/cm(2) were seen after exposure to antimicrobial agents alone, with the exception of a 4.57-log-unit reduction for S. epidermidis and trimethoprim-sulfamethoxazole. We detected a statistically significant bioelectric effect when vancomycin plus 2,000 microamperes EC were used against MRSA biofilms (P = 0.04) and when dapt...Continue Reading

References

May 1, 1977·Clinical Orthopaedics and Related Research·C T BrightonR E Booth
Jul 1, 1992·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·A E KhouryJ W Costerton
Nov 1, 1992·Applied and Environmental Microbiology·S A BlenkinsoppJ W Costerton
Nov 1, 1990·Antimicrobial Agents and Chemotherapy·H AnwarJ W Costerton
Oct 8, 1990·Biochimica Et Biophysica Acta·G Cevc
Jan 1, 1987·Annual Review of Microbiology·J W CostertonT J Marrie
Dec 1, 1994·Antimicrobial Agents and Chemotherapy·J W CostertonA E Khoury
Sep 1, 1995·Journal of Industrial Microbiology·J JassH M Lappin-Scott
Sep 1, 1996·Antimicrobial Agents and Chemotherapy·N WellmanB R McLeod
Dec 1, 1996·The Journal of Antimicrobial Chemotherapy·J Jass, H M Lappin-Scott
Sep 26, 1997·Antimicrobial Agents and Chemotherapy·P StoodleyH M Lappin-Scott
Mar 15, 2000·Archives of Oral Biology·W Wattanakaroon, P S Stewart
Mar 21, 2001·Antimicrobial Agents and Chemotherapy·K Lewis
Jun 10, 2003·The Journal of Bone and Joint Surgery. British Volume·S A W PickeringB E Scammell
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Giorgia BorrielloPhilip S Stewart
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·R CaubetW J Ellison
Jun 1, 2007·Clinical Pharmacology and Therapeutics·J L del Pozo, R Patel

❮ Previous
Next ❯

Citations

Apr 5, 2011·Journal of Industrial Microbiology & Biotechnology·Minna PeltolaMirja Salkinoja-Salonen
Jul 2, 2011·Biofouling·Cláudia SousaRosário Oliveira
Apr 25, 2014·Advances in Wound Care·Mohammad Reza Asadi, Giti Torkaman
Jan 3, 2013·Expert Review of Medical Devices·David FreebairnSean P Gorman
Jan 31, 2012·Infectious Disease Clinics of North America·Paschalis Vergidis, Robin Patel
Sep 21, 2015·Biotechnology Letters·Shilpi Srivastava, Atul Bhargava
Sep 25, 2010·Journal of Microbiological Methods·Paul Matewele
Nov 26, 2015·Biofouling·Sujala T SultanaHaluk Beyenal
Apr 14, 2016·International Journal of Bacteriology·Maria Ruiz-RuigomezRobin Patel
Jan 15, 2015·Diagnostic Microbiology and Infectious Disease·Alice TzengKhaled J Saleh
Jan 27, 2015·Diagnostic Microbiology and Infectious Disease·Choon K KimGovindarajan Rajagopalan
Dec 30, 2015·Antimicrobial Agents and Chemotherapy·Paul VoegeleRobin Patel
Jan 5, 2012·Clinical Orthopaedics and Related Research·Mohit GilotraSteven C Ludwig
Jun 21, 2019·Journal of Materials Science. Materials in Medicine·Iker De-la-PintaGuillermo Quindós
Jan 23, 2020·Applied Microbiology and Biotechnology·Ram Anand VadlamaniAllen L Garner
Aug 9, 2019·Clinical Orthopaedics and Related Research·Nina M MuñozAlda L Tam
Jun 21, 2020·Applied and Environmental Microbiology·Venkata Rao KrishnamurthiYong Wang
Jan 4, 2017·BioMed Research International·Thomas Josef DaubenRainer Bader
Aug 11, 2020·Archives of Microbiology·Chengrong LuQingping Zhong
Dec 14, 2017·Expert Review of Anti-infective Therapy·Jose Luis Del Pozo
Jan 19, 2019·Materials·Humberto PalzaCarolina Angulo-Pineda
May 28, 2019·JBMR Plus·Suzannah M Schmidt-MalanRobin Patel
Sep 23, 2015·NPJ Biofilms and Microbiomes·Young Wook KimReza Ghodssi
Oct 16, 2018·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Mohammed AshrafiArdeshir Bayat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.